Failure to Complete Required AIMS Assessments for Residents on Antipsychotic Medications
Penalty
Summary
The facility failed to provide services that meet professional standards of practice for two residents who were prescribed antipsychotic medications. For both residents, the required Quarterly Abnormal Involuntary Movement Scale (AIMS) assessments, which are used to monitor for side effects of antipsychotic medications, were not completed. Specifically, one resident with diagnoses including severe unspecified dementia with psychotic disturbance, unspecified mood disorder, and unspecified psychosis had been taking Seroquel 50mg twice daily, but the AIMS assessment initiated was left completely blank, and no other AIMS assessments were found in the medical record. Another resident with diagnoses including vascular dementia, psychotic disorder with delusions due to a known physiological condition, mood disorder due to a known physiological condition with mixed features, major depression disorder unspecified, and anxiety disorder unspecified had been receiving Olanzapine 2.5mg daily, but their AIMS assessment was also left blank, with no other completed assessments found in the record. Interviews with licensed nursing staff and the Director of Nursing (DON) confirmed that both residents had been on antipsychotic medications for several months and that the AIMS assessments were incomplete or missing. The DON acknowledged that facility policy requires AIMS assessments to be performed quarterly for any resident on an antipsychotic and that these assessments had not been completed as required for the two residents. The failure to complete these assessments was confirmed through both record review and staff interviews.